Brainstorm Cell Therapeutics Inc.
(NASDAQ : BCLI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Loading BCLI News...
...
Electronic Technology » Computer Peripherals
symbolcompany%chnglast%shortavg$volume
WDCWestern Digital Corporation
3.92%89.072.3%$456.01m
STXSeagate Technology PLC
-0.40%42.138.8%$265.79m
NTAPNetApp, Inc.
0.25%39.862.9%$112.59m
SYNASynaptics Incorporated
3.59%54.7718.1%$40.19m
EFIIElectronics For Imaging, Inc.
-1.84%45.7813.0%$29.01m
ZBRAZebra Technologies Corporation Class A
0.12%94.274.2%$27.66m
LOGILogitech International S.A.
1.62%33.184.9%$15.77m
PSTGPure Storage, Inc. Class A
0.90%10.617.8%$12.71m
QTMQuantum Corporation
-0.13%7.930.6%$4.31m
AVIDAvid Technology, Inc.
1.17%5.6112.1%$2.66m
IMMRImmersion Corporation
-3.20%8.775.4%$1.59m
BCLIBrainstorm Cell Therapeutics Inc.
-1.20%4.135.3%$1.58m
QBAKQualstar Corporation
6.14%7.090.8%$0.51m
ALOTAstro-Med, Inc.
-0.67%14.900.5%$0.28m
ICADiCAD, Inc.
-2.95%5.590.5%$0.25m

Company Profile

Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops innovative adult stem cell therapeutic products. It currently focuses on utilizing the patients own bone marrow stem cells to generate neuron-like cells that may provide an effective treatment initially for amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis and spinal cord injury. The company was founded on September 22, 2000 and is headquartered in Hackensack, NJ.